calendar

5 catalysts · 5 approval

next 91 dayslessmore

MonWedFri

view

sort

type

therapy area

no tagged catalysts yet

Week of Sep 14, 2015

›Sep 16, 2015approval3982d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

›Sep 16, 2015approval3982d agoAFREZZA (INSULIN RECOMBINANT HUMAN) — FDA approvalinsulin human

Sponsor: MANNKIND. Form: POWDER. Route: INHALATION

›Sep 16, 2015approval3982d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

›Sep 16, 2015approval3982d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

›Sep 16, 2015approval3982d agoSOJOURN (SEVOFLURANE) — FDA approvalSEVOFLURANE

Sponsor: PIRAMAL CRITICAL. Form: LIQUID. Route: INHALATION

$MNKD3.9300-4.38%